CAT# | CPM-1-0587 |
Sequence | KIFGSLAFL |
Size | 50 Test, 100 Test | Antigen | Cancer | Epitope Origin | Her-2/neu E75 | MHC Restriction | HLA-A_02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0614 | HLA-A_02_01 topo II tetramer-FLYDDNQRV-APC labeled | Inquiry | ||
CPM-1-0427 | HLA-A_24_02 LY6K tetramer-RYCNLEGPPI-BV421 labeled | Inquiry | ||
CPM-1-0592 | HLA-B_27_05 HIV gag tetramer-KRWIILGLNK-PE labeled | Inquiry | ||
CPM-1-0552 | HLA-B_35_01 CMV pp65 tetramer-IPSINVHHY-APC labeled | Inquiry | ||
CPM-1-0176 | BF2_1501 IBV NP tetramer-WRRQARYK-APC labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
The β-amyloid precursor protein (APP) is connected to Alzheimer's disease by both biochemistry and genetics. As ...
Cyclotraxin B , a potent antagonist of TrkB receptors, inhibits BDNF-induced TrkB activity (IC50 = 0.30 nM). R ...
Elcatonin acetate, a physicochemically and biologically stable synthetic derivative of calcitonin transformed fr ...
Lecirelin, a synthetic hormone, is a strongly basic nonapeptide with sequence yr-His-Trp-Ser-Tyr-tBu-D-Gly-Leu-A ...
Discovery and Structure Calcitonin, also called thyrocalcitonin, a protein hormone synthesized and secreted in humans and oth ...